Algorithm
graph TD classDef step1 fill:#E6F0FA,stroke:#004080,stroke-width:2px,color:#004080 classDef step2 fill:#EAF7EA,stroke:#1A661A,stroke-width:2px,color:#1A661A classDef step3 fill:#F4EBFA,stroke:#4C1A80,stroke-width:2px,color:#4C1A80 classDef step4 fill:#FAEFE6,stroke:#994C00,stroke-width:2px,color:#994C00 classDef step5 fill:#E6ECE6,stroke:#264D26,stroke-width:2px,color:#264D26 classDef alert fill:#FAE6E6,stroke:#990000,stroke-width:2px,color:#990000 A[Approach to a Dysmorphic Child]:::step1 --> B[Step 1: History Taking]:::step1 B --> B1[Pedigree, Antenatal, Perinatal, Developmental]:::step1 B1 --> C[Step 2: Physical Examination]:::step2 C --> C1[Systematic head-to-toe anthropometry and assessment]:::step2 C1 --> D{3 or more minor anomalies?}:::alert D -- Yes --> D1[High likelihood of underlying genetic syndrome]:::alert D -- No --> E D1 --> E[Step 3: Pattern Recognition]:::step3 E --> E1[Isolated Malformation]:::step3 E --> E2[Multiple Congenital Anomalies]:::step3 E --> E3[Recognizable Pattern: Syndrome, Sequence, or Association]:::step3 E1 --> F[Step 4: Tiered Investigations]:::step4 E2 --> F E3 --> F F --> F1{Clinical Indication}:::step4 F1 -- Developmental delay, dysmorphism, or MCA --> G1[First-Tier: Chromosomal Microarray - CMA]:::step4 F1 -- Suspected classic aneuploidy --> G2[First-Tier: Conventional Karyotyping]:::step4 F1 -- Suspected specific microdeletion / microduplication --> G3[Targeted: FISH or MLPA]:::step4 F1 -- Specific clinical clues --> G4[Ancillary: Imaging and Biochemical]:::step4 G1 -- Unresolved / Consanguinity / Family History --> G5[Second-Tier: Whole Exome Sequencing - WES]:::step4 G2 --> H[Step 5: Multidisciplinary Management]:::step5 G3 --> H G4 --> H G5 --> H H --> H1[Clinical Genetics Referral]:::step5 H --> H2[Pediatric Subspecialty Care]:::step5 H --> H3[Corrective Surgical & Developmental Interventions]:::step5 H --> H4[Syndrome-Specific Surveillance]:::step5
Definition And Objectives
- A dysmorphic child exhibits one or more congenital anomalies or unusual physical features that fall outside the normal phenotypic spectrum for age, sex, and ethnicity.
- These features may occur as isolated defects, multiple congenital anomalies (MCA), or as part of a recognizable pattern such as a syndrome, sequence, association, or field defect.
- The primary objectives of systematic evaluation include establishing a precise diagnosis, detecting life-threatening or correctable anomalies early, providing accurate genetic counseling, and guiding multidisciplinary management and long-term surveillance.
Step 1: History Taking
- Pedigree: Construct a three-generation pedigree emphasizing consanguinity, recurrent miscarriages, neonatal deaths, intellectual disability, or known genetic disorders in relatives.
- Antenatal History: Document maternal age, parity, teratogen exposure (alcohol, anticonvulsants, isotretinoin, TORCH infections), maternal diabetes, and prenatal ultrasound anomalies (intrauterine growth restriction, oligohydramnios, structural defects).
- Perinatal History: Note gestational age, birth weight, Apgar scores, NICU admission, feeding difficulties, and neonatal seizures.
- Developmental And Systemic History: Assess age at attainment of milestones, developmental regression, behavioral issues, recurrent infections, and cardiac or skeletal symptoms.
Step 2: Physical Examination
A systematic head-to-toe assessment is essential to document all findings with precise terminology.
| Examination Area | Key Features To Assess |
|---|---|
| Anthropometry | Serial plotting of weight, length, and head circumference; classify proportionate versus disproportionate growth, microcephaly, or macrocephaly. |
| Craniofacial | Head shape, fontanelle status, eye spacing (hypertelorism/hypotelorism), palpebral fissure slant, epicanthal folds, ear position/shape, cleft lip/palate, and micrognathia. |
| Neck And Trunk | Short/webbed neck, pectus excavatum/carinatum, scoliosis, heart murmurs, abdominal organomegaly, and ambiguous genitalia. |
| Limbs And Extremities | Digit number and arrangement (polydactyly, syndactyly, clinodactyly), single palmar crease, limb reduction defects, and joint contractures. |
| Skin And Neurological | Pigmentary changes (cafe-au-lait macules), muscle tone (hypotonia/hypertonia), deep tendon reflexes, and primitive reflexes. |
- The presence of three or more minor anomalies significantly increases the likelihood of an underlying genetic syndrome.
Step 3: Pattern Recognition And Classification
- Categorize the findings as an isolated malformation, multiple congenital anomalies, or a recognizable pattern.
- Differentiate between a sequence (a cascade of defects arising from a single primary anomaly, such as Pierre-Robin sequence), an association (non-random co-occurrence of anomalies without a single known etiology, such as VACTERL), and a syndrome (multiple anomalies related by a single genetic or chromosomal etiology, such as Down syndrome or Trisomy 18).
Step 4: Tiered Investigations
Adopt a hypothesis-driven approach, prioritizing least invasive and highest-yield testing.
| Testing Tier | Investigation Modality | Clinical Indication |
|---|---|---|
| First-Tier Genetic | Chromosomal Microarray (CMA) | First-line for developmental delay, intellectual disability, dysmorphism, or multiple congenital anomalies; detects copy number variants. |
| First-Tier Genetic | Conventional Karyotyping | Suspected classic aneuploidy (e.g., Trisomy 21) or to detect balanced rearrangements. |
| Targeted Testing | FISH or MLPA | Suspected specific microdeletion or microduplication (e.g., 22q11.2 deletion syndrome, Williams syndrome). |
| Second-Tier Genetic | Whole Exome Sequencing (WES) | Unresolved cases, consanguinity, or strong family history following a negative CMA; utilizes a trio approach (proband plus parents). |
| Ancillary | Imaging and Biochemical | Echocardiography for murmurs, renal ultrasound, skeletal survey, brain MRI, and metabolic screening (e.g., urine glycosaminoglycans) based on specific clinical clues. |
Step 5: Multidisciplinary Management Planning
- Referral: Facilitate early referral to a clinical geneticist for variant interpretation, syndrome confirmation, and recurrence risk counseling.
- Subspecialty Care: Involve pediatric subspecialists such as cardiologists, neurologists, nephrologists, and orthopedists for comorbidity management.
- Interventions: Plan corrective surgical interventions for clefts, cardiac defects, or limb anomalies, and initiate early developmental therapies (physiotherapy, speech therapy).
- Surveillance: Implement syndrome-specific surveillance protocols (e.g., tumor screening in Beckwith-Wiedemann syndrome, thyroid function monitoring in Down syndrome).